Stock Market News

2 weeks Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?Zacks

BMY has been having a good run for the past three months. The stock recently touched a 52-week high. We believe there is more room for growth, and any dip in share price can be used as a buying opportunity.

Biotech · Bristol · Bristol-Myers Squibb (BMY)

14 hours 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise MoveThe Motley Fool X

14 hours 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise MoveThe Motley Fool X

1 day AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied SetbackInvestor's Business Daily X

1 day Replimune Stock Rallies on BLA Filing for Melanoma Combo DrugZacks X

2 days Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?The Motley Fool X

2 days Got $500? 1 Biotech Stock to Buy and Hold ForeverThe Motley Fool X

2 days OK, Here is the main reason that why Biotech companies don’t make money in ChinaReddit X

2 days OK, Here is the main reason that why Biotech companies don’t make money in ChinaReddit X

2 days Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why is NVO willing to sell drugs at such low price in China?Reddit X

2 days Why is NVO willing to sell drugs at such low price in China?Reddit X

2 days Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days 10 Worst Performing Biotech Stocks in 2024Insider Monkey X

2 days Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreZacks X

3 days Is Bristol Myers Squibb Stock a Buy?The Motley Fool X

3 days China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drugInvesting.com X

4 days Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

4 days Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?Zacks X

4 days Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

4 days Regeneron: The Biotech Stock To Buy NowSeeking Alpha X

4 days Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade)Seeking Alpha X

5 days Best Biotech Stocks Right NowBenzinga X

5 days The Zacks Analyst Blog Highlights SPDR S&P Biotech ETF, SPDR S&P Semiconductor ETF, First Trust Indxx Aerospace & Defense ETF, First Trust NASDAQ-100-Technology Sector Index Fund and iShares U.S. Digital Infrastructure and Real Estate ETFZacks X

5 days Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climateMarketWatch X

6 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

6 days Biotech Stocks To Watch And Pharma Industry NewsInvestor's Business Daily X

6 days Bristol-Myers Squibb: Buy This Bargain Before It’s GoneSeeking Alpha X

7 days Is It Too Late to Buy Viking Therapeutics Stock?The Motley Fool X

1 week 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

1 week 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or MoreThe Motley Fool X

1 week RBC’s top 10 questions and answers on biotech stocksInvesting.com X

1 week Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer TherapyZacks X

1 week The Cream Of The Crop: 5 Biotechs That Outrank Most StocksInvestor's Business Daily X

1 week Trump Taps RFK for HHS: Time to Avoid Biotech?Zacks X

1 week Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call TranscriptInsider Monkey X

1 week Where Will CRISPR Therapeutics Be in 3 Years?The Motley Fool X

1 week Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

1 week The Stocks Our Experts Are Trading NowInvestorPlace X

1 week Ocugen (OCGN) Reports Q3 Loss, Misses Revenue EstimatesZacks X

1 week Sagimet: More Than Just A MASH Drug Development BiotechSeeking Alpha X

1 week Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataZacks X

1 week BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock UpZacks X